GEN Exclusives

More »

GEN News Highlights

Back to Item »

Novartis Picks Up Cytos’ Nicotine Addiction Vaccine for Approximately $499M

Firm will develop, manufacture, and commercialize CYT002-NicQb under a worldwide, exclusive license.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?